North America Creatinine Measurement Market is expected to reach US$ 269.75 Mn by 2027


PRESS RELEASE BY The Insight Partners 12 May 2020

Share this press on


Jaffe’s kinase method segment is expected to drive the growth of the global creatinine measurement market by product type

 

According to the latest study on 'Creatinine measurement Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product Type and End User'. The North America creatinine measurement market was valued at US$ 148.79 million in 2019 and is projected to reach US$ 269.75 million by 2027; it is expected to grow at a CAGR of 7.8% during 2020–2027. The report highlights the trends prevailing in the North America creatinine measurement market and the factors driving the market along with those that act as deterrents to its growth.

 

Based on product, the North America creatinine measurement market is segmented into kits and reagents. The reagents segment held the largest share of the market in 2019 and it is expected to continue its dominance during the forecast period. The large share of is attributed to the low cost and easy accessibility of reagents as compared to the commercially available kits are likely to augment the growth of the segment in the creatinine measurement market.

 

Factors such as the increasing prevalence of chronic kidney disorders, growing geriatric population are driving the market growth. However, the shift toward novel biomarkers will impede the market growth. Furthermore, emerging markets in developing countries is likely to offer significant opportunities for the growth of the creatinine measurement market.

 

Siemens Healthcare Gmbh, Abbott, Cayman Chemical, Thermo Fisher Scientific Inc., Fujifilm Wako Pure Chemical Corporation, Randox Laboratories Ltd, F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. ,Maccura Biotechnology Co., Ltd., Diazyme Laboratories, Inc, are some of the notable companies present in the creatinine measurement market. Various companies are focusing on inorganic growth strategies such as mergers & acquisitions, partnerships, collaborations, and acquisitions. For instance, in May 2018, Abbott launched a product namely, Afinion 2 analyzer in the U.S. The product is the newest generation of the Afinion test system.

 

North America Creatinine measurement Market, By Country, 2019 (%)

 North America Creatinine measurement Market, By Country, 2019 (%)


North America Creatinine Measurement Market to Grow at a CAGR of 7.8% to reach US$ 269.75 Million from 2020 to 2027

Download Free Sample

North America Creatinine Measurement Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Kits, Reagents); Type (Enzymatic Method, Jaffe's Kinetic Method); Sample Type (Blood or Serum, Urine); End-User (Hospitals, Diagnostic Laboratories, Others), and Country

The report segments the North America creatinine measurement market as follows:

By Product

  • Reagents
  • Kits

By Type

  • Jaffe’s Kinetic Method
  • Enzymatic Method

By Sample Type

  • Blood or Plasma
  • Urine

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Others

By Country

  • US
  • Canada
  • Mexico

Contact Us
 
Phone: +1-646-491-9876
Download Free PDF Brochure